title: Degradation of rat chondrosarcoma proteoglycans by a neutral metalloprotease from rabbit chondrocytes.
abstract: Rat chondrosarcoma proteoglycan aggregate with radiolabeled core protein was digested with a chondrocyte metalloprotease (CMP) or clostripain (CP) at neutral pH. The rates of product formation and the sizes and antigenicities of the products were studied using column chromatography and monoclonal antibodies. Sixteen percent of [35S]methionine label and 17-18% of [3H]serine label in core protein were freed from glycosaminoglycan bound peptides by 50 U/ml (760 micrograms/ml) of CP or 10 micrograms/ml (estimated) of CMP in 180 min. The CP reaction was almost complete at 5 minutes while the CMP reaction proceeded slowly from 5 to 180 min. The chondroitin-sulfate rich fragments were smaller after CP than CMP treatment. The 180 min CMP digest contained protein that migrated in 2 peaks on Sepharose CL6B. These two peaks corresponded to the peaks where hyaluronic acid binding region produced by CP and link protein migrate. Metalloenzyme inhibitors inhibited CMP with IC50s of 5 x 10(-5)M, 1 x 10(-3)M, and 80 micrograms/ml for phenanthroline, EDTA, and alpha 2-macroglobulin, respectively.
authors.affiliation: Department of Pharmacology, ICI Americas Inc. Wilmington, DE 19897.
authors.forename: C B
authors.initials: CB
authors.lastname: Caputo
authors.forename: L A
authors.initials: LA
authors.lastname: Sygowski
authors.forename: S P
authors.initials: SP
authors.lastname: Patton
authors.forename: R F
authors.initials: RF
authors.lastname: Piehl
authors.forename: R G
authors.initials: RG
authors.lastname: Caccese
authors.forename: G
authors.initials: G
authors.lastname: Dipasquale
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D002356:Cartilage / Q000166:cytology / Q000201:enzymology*; D002813:Chondrosarcoma / Q000378:metabolism*; D003546:Cysteine Endopeptidases / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000494:pharmacology; D008666:Metalloendopeptidases / Q000378:metabolism / Q000494:pharmacology*; D009930:Organic Chemicals; D010396:Penicillamine / Q000494:pharmacology; D011509:Proteoglycans / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D013498:Suramin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000378:metabolism*
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006025:Glycosaminoglycans; D009930:Organic Chemicals; D011509:Proteoglycans; D013498:Suramin; C010034:Arteparon; C029841:CL 205241; D003546:Cysteine Endopeptidases; C019913:clostripain; D008666:Metalloendopeptidases; D010396:Penicillamine